David Bond
Physician · Ohio State University College of Medicine
Credentials: · · · · ·
History
Research
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
New England Journal of Medicine · 2022 · 456 citations
Targeting BTK in CLL: Beyond Ibrutinib
Review · Current Hematologic Malignancy Reports · 2019 · First of 2 authors · 115 citations
Blood · 2021 · 94 citations
44 papers
26 papers
- YS
26 papers
21 papers
21 papers
19 papers
18 papers · 1 as a fellow
- TV
17 papers · 5 as a fellow
